AVBP

$12.239.34%-1.26

Pre-market: 12.48+0.25 +2.04%

Arrivent Biopharma Inc (AVBP)

Arrivent Biopharma Inc Stock (AVBP) Forecast

The Arrivent Biopharma Inc (AVBP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.11, representing a +15.41% increase from the current price of $12.23. The highest analyst price target is $16.30, and the lowest is $11.92.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month AVBP Price Target

Average 19.25 (+57.40% Upside)

Is Arrivent Biopharma Inc (AVBP) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	28.06	Buy
STOCH(9,6)	6.65	Buy
STOCHRSI(14)	24.07	Neutral
MACD(12,26)	-2.86	Sell
ADX(14)	33.49	Sell
William %R	-99.45	Buy
CCI(14)	-112.52	Sell

Buy: 3 · Sell: 3 · Neutral: 1Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	15.04 Sell	14.67 Sell
MA20	16.22 Sell	16.79 Sell
MA50	23.40 Sell	21.45 Sell
MA100	27.48 Sell	24.56 Sell
MA200	26.78 Sell	25.24 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, AVBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on AVBP, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 28.06 indicates that AVBP is oversold. This indicates that AVBP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
STOCH (Stochastic Oscillator): The STOCH value of 6.65 indicates that AVBP is oversold. This indicates that AVBP price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.07 indicates that AVBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 33.49 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -112.52 indicates that AVBP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term AVBP price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Arrivent Biopharma Inc financial reports and earnings history, Arrivent Biopharma Inc (AVBP) stock could reach $24.56 by 2030, $9.79 by 2040 and $26.57 by 2050. See the projected annual prices until 2050 of the Arrivent Biopharma Inc stock below:

Arrivent Biopharma Inc (AVBP) is expected to reach an average price of $15.76 in 2035, with a high prediction of $21.77 and a low estimate of $1.35. This indicates an +28.83% change from the last recorded price of $12.23.
Arrivent Biopharma Inc (AVBP) stock is projected to chart a bullish course in 2040, with an average price target of $2.03, representing an -83.38% change from its current level. The forecast ranges from a conservative $0.4728 to a sky-high $9.79.
Our analysts predict Arrivent Biopharma Inc (AVBP) to change +135.52% by 2045, soaring from $0.0516 to an average price of $28.80, potentially reaching $26.75. While $0.0516 is the low estimate, the potential upside is significant.
Arrivent Biopharma Inc (AVBP) stock is expected to climb by 2050, reaching an average of $18.60, a +52.06% change from its current level. However, a wide range of estimates exists, with high and low targets of $26.57 and $17.42, respectively, highlighting the market's uncertainty.

Arrivent Biopharma Inc Stock (AVBP) Year by Year Forecast

Arrivent Biopharma Inc Stock (AVBP) Price Forecast for 2026

The predicted value for Arrivent Biopharma Inc (AVBP) in 2026 is set at an average of $24.89. Estimates vary from a peak of $35.83 to a trough of $11.36, indicating an +103.54% surge from the present price of $12.23.

Month	Average	Low	High	Change from today's price
December, 2026	$14.52	$11.92	$16.30	+18.73%

Arrivent Biopharma Inc Stock (AVBP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Arrivent Biopharma Inc (AVBP) is $17.61, with a high forecast of $30.47 and a low forecast of $8.03. This indicates an +43.96% increase from the last price of $12.23.

Month	Average	Low	High	Change from today's price
January, 2027	$11.49	$10.53	$16.58	-6.03%
February, 2027	$9.12	$8.03	$12.76	-25.40%
March, 2027	$12.99	$9.06	$14.75	+6.20%
April, 2027	$11.80	$9.33	$14.01	-3.52%
May, 2027	$16.24	$9.61	$16.91	+32.83%
June, 2027	$18.28	$14.03	$18.89	+49.44%
July, 2027	$17.73	$16.27	$24.96	+44.96%
August, 2027	$22.27	$16.38	$23.13	+82.12%
September, 2027	$24.86	$21.47	$26.47	+103.31%
October, 2027	$24.10	$19.77	$30.47	+97.02%
November, 2027	$20.84	$19.18	$24.55	+70.41%
December, 2027	$21.55	$17.87	$22.72	+76.23%

Arrivent Biopharma Inc Stock (AVBP) Price Forecast for 2028

In 2028, Arrivent Biopharma Inc (AVBP) is projected to reach an average price of $14.76, with a high projection of $23.98 and a low estimate of $9.88. This indicates an +20.67% rise from the last price of $12.23.

Month	Average	Low	High	Change from today's price
January, 2028	$17.93	$17.49	$23.98	+46.58%
February, 2028	$13.32	$12.26	$17.98	+8.90%
March, 2028	$12.56	$9.88	$13.32	+2.70%
April, 2028	$14.62	$11.86	$16.25	+19.56%
May, 2028	$17.81	$12.99	$19.61	+45.60%
June, 2028	$15.36	$14.59	$20.35	+25.58%
July, 2028	$13.31	$13.20	$17.99	+8.85%
August, 2028	$13.82	$10.78	$15.89	+13.04%
September, 2028	$12.79	$11.86	$15.72	+4.55%
October, 2028	$13.42	$11.81	$16.65	+9.74%
November, 2028	$15.22	$11.85	$15.98	+24.47%
December, 2028	$16.93	$15.31	$20.73	+38.46%

Arrivent Biopharma Inc Stock (AVBP) Price Forecast for 2029

The 2029 price forecast for Arrivent Biopharma Inc Stock (AVBP) is $20.75 on average, with a high prediction of $31.14 and a low estimate of $6.90. This represents an +69.70% increase from the previous price of $12.23.

Month	Average	Low	High	Change from today's price
January, 2029	$15.85	$13.18	$18.32	+29.59%
February, 2029	$17.50	$15.04	$21.00	+43.09%
March, 2029	$18.99	$16.98	$22.30	+55.29%
April, 2029	$20.62	$15.85	$22.91	+68.58%
May, 2029	$25.20	$20.79	$27.32	+106.04%
June, 2029	$25.53	$21.16	$26.42	+108.75%
July, 2029	$30.06	$23.58	$31.14	+145.83%
August, 2029	$27.11	$22.78	$30.95	+121.64%
September, 2029	$24.55	$24.00	$28.04	+100.72%
October, 2029	$24.39	$22.77	$27.21	+99.45%
November, 2029	$12.27	$6.90	$27.00	+0.36%
December, 2029	$6.98	$6.98	$16.80	-42.93%

Arrivent Biopharma Inc Stock (AVBP) Price Forecast for 2030

Arrivent Biopharma Inc Stock (AVBP) is expected to reach an average price of $10.61 in 2030, with a high forecast of $24.56 and a low forecast of $1.72. This signifies an -13.26% decrease from the last price of $12.23.

Month	Average	Low	High	Change from today's price
January, 2030	$9.55	$6.41	$10.18	-21.89%
February, 2030	$6.80	$5.48	$10.17	-44.43%
March, 2030	$5.74	$4.16	$7.54	-53.07%
April, 2030	$4.65	$1.72	$5.86	-61.98%
May, 2030	$6.93	$4.27	$8.50	-43.31%
June, 2030	$6.18	$3.13	$7.43	-49.50%
July, 2030	$9.66	$4.89	$10.78	-21.05%
August, 2030	$12.13	$7.93	$12.80	-0.83%
September, 2030	$10.99	$10.24	$18.93	-10.16%
October, 2030	$17.25	$11.01	$18.03	+41.06%
November, 2030	$22.38	$16.49	$24.56	+83.03%
December, 2030	$15.04	$13.68	$23.14	+23.01%

Similar to AVBP